Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
Not sure what happened with the link, it was working today:
https://bnf.nice.org.uk/drug/interferon-beta.html
Parsley2 I take your points well and confess to "a little knowledge being a dangerous thing" but surely the case for interferon-beta is quite a different matter? The side effects under many circumstances seem to be noted and acknowledged by NICE (https://bnf.nice.org.uk/drug/interferon-beta.html).
I'd better leave it at that as I have no understanding of the science involved, I was just trying to further my understanding of why the therapeutic use of SNG001 seems to be such a drawn-out process in the face of global emergency use approval of other therapeutic drugs.
Manifesto: that's so simple isn't it? Positive test, take home some SNG001 to inhale each day. Just think of the cost savings to the NHS. Given that most of us on this board would agree and that it's pretty clear SNG001 is not harmful, why are things moving so slowly for it?
https://www.parliamentlive.tv/Event/Index/31e5cbee-1b69-4137-9c72-f0231cd32686
I begin to wonder when there will be some official mention of SNG001. Maybe it's just my impatience but the silence in ministerial circles is deafening.
Loren ipsum isn’t really Latin, it’s just as you suspect - copy that typesetter use to fill space until the real copy can be added.
At last: Hanck’s Half Hour is going to be pivotal.
You have to think something is wrong with the information we have; day after day, share price falls away. It’s not just a couple of days either, it’s a longer term erosion of shareholder value that doesn’t stack up with recent rns statements. Wonder if it will reach a point where BoD issue a note to say they don’t know why SP has fallen so far.
Agree but supposing you had sold, how do you decide when to step back in (asking for a friend)?
Must be more.
Agree PI's struggle to short-term trade (some must make money by selling on the 10% rise and buying back in minutes with a 7% or 8% profit).
But the business must be worth more than it was before the rns.
Always the case: up almost 10% at opening, but can't sell anything through AJBell. Once it gets back to last night's close, I'll have no trouble selling. Go figure.
Gidget thanks, I was hoping someone would say that! I've looked again and still can't find any ignificant downside from the information us PI's have.
Washington Post too. Gaining traction?
https://www.washingtonpost.com/nation/2020/08/28/arizona-coronavirus-wastewater-testing/
If seller finished, maybe now this share will get a more realistic SP. Let's hope so!
That's a well-written and reasoned short article. You feel you can trust the author and it all points to the continuing importance of through cleaning.
Patience wears thin and I wonder what a professional investor would do (have done) by now. Down 40% since earlier in the year, even though business should be booming and I can't find any fundamental "sell" signals.
Probably should have dumped this some while back yet tempted to add to holding at this price on same fundamentals.
What would you do?
Agree they are doing well, not just because of Covid. Used to be a staple food sector performer then really lost it several years back. Now pension funding is looking brighter, brand strategy in place, new management, and most important of all, new CEO. It's a serious prospect for long-term investors once again. Hurrah!